Eikonoklastes Closes Oversubscribed Series A Financing, Helping to Advance Immunotherapies Toward Clinical Trial Stage

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2UbOgjS
via IFTTT